SCHEMBL25976597

SCHEMBL25976597

Cc1ccc(-c2cc(-c3cc(-c4ccccc4)ccc3C)[n+](C)cc2C)c(C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
HTT P42858 3/20 0.39
LMNA P02545 2/20 0.39
HPRT1 P00492 1/20 0.33
NPC1 O15118 3/20 0.33
NTSR1 P30989 1/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ESR2 Q92731 1/20 0.33
APAF1 O14727 1/20 0.33
THRB P10828 1/20 0.33
XBP1 P17861 1/20 0.33
PTBP1 P26599 1/20 0.33
GALK1 P51570 1/20 0.33
BLM P54132 1/20 0.33
SMAD3 P84022 1/20 0.33
ATM Q13315 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25976921 0.90 TRPA1 (0.35) ESR2CA12CA1CA2CA9
SCHEMBL25976558 0.89 SLC6A9 (0.38) RAB9ASMN1; SMN2HTTLMNANPC1
SCHEMBL25976685 0.86 LMNA (0.37) RAB9ASMN1; SMN2HTTLMNANPC1
SCHEMBL25976556 0.86 HTT (0.36) RAB9ASMN1; SMN2HTTLMNAHPRT1
SCHEMBL25976598 0.85 PSMB5 (0.35) RAB9ASMN1; SMN2HTTLMNAHPRT1
SCHEMBL25976980 0.83 ELANE (0.34) RAB9ASMN1; SMN2HTTLMNANPC1
SCHEMBL25446048 0.83 ESR2 (0.41) RAB9ASMN1; SMN2HTTLMNANPC1
SCHEMBL25452197 0.82 HTT (0.37) RAB9ASMN1; SMN2HTTLMNAHPRT1
SCHEMBL25976552 0.82 RAB9A (0.36) RAB9ASMN1; SMN2HTTLMNAHPRT1
SCHEMBL25976595 0.81 TYMS (0.36) RAB9ASMN1; SMN2HTTLMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331758-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-19 US disclosed
US-11725021-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11725021-B2 Organic electroluminescent materials and devices NCL, OCIAD2, OCIAD1 RAB9A 1939/4885SMN1; SMN2 3169/4885HTT 3085/4885
US-20230331758-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES NCL, OCIAD2, OCIAD1 RAB9A 1939/4885SMN1; SMN2 3169/4885HTT 3085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.